scanX
Apollo Hospitals
add_icon

Apollo Hospitals

8,097.00
+260.00
(3.32%)
Market Cap
1,16,422.44 Cr
PE Ratio
60.40
Volume
9,22,866.00
Day High - Low
8,115.00 - 7,812.50
52W High-Low
8,099.50 - 6,677.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,16,422.44 Cr
EPS
100.56
PE Ratio
60.40
PB Ratio
12.40
Book Value
631.88
EBITDA
3,222.10
Dividend Yield
0.16 %
Industry
Healthcare Services
Sector
Hospitals
Return on Equity
17.39
Debt to Equity
0.61
Analyst Rating and Forecast
- By Refinitiv from26 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+92.31 %
+92.31 %
Hold
Hold+3.85 %
+3.85 %
Sell
Sell+3.85 %
+3.85 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Apollo Hospitals Gets NCLT Order on Composite Scheme1 day ago
Apollo Hospitals received the certified true copy of the NCLT order dated May 5, 2026, related to a composite scheme of arrangement involving Apollo Healthco, Keimed, and Apollo Healthtech.
neutral
Apollo Hospitals Records ₹40.52 Cr NSE Block Trade4 days ago
Apollo Hospitals Enterprise Ltd. recorded a block trade on NSE worth ₹40.52 crores, involving approximately 52,208 shares at a price of ₹7761.00 per share.
neutral
Apollo Hospitals to Consider Q4 Results on May 206 days ago
Apollo Hospitals Enterprise Limited has scheduled a Board of Directors meeting on May 20, 2026, to approve audited FY26 financial results and consider a final dividend.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Apollo Hospitals
8,097.00
#1 1,16,422.44
#4 60.40
#1 21,994.30
#5 14.76
#1 1,505
#3 36.08
68.54
Max Healthcare Institute
1,012.50
98,529.92
69.62
7,184.10
#1 28.68
1,076
26.01
55.30
Fortis Healthcare
952.35
71,898.44
72.94
7,849.70
13.25
809
-22.38
64.64
Aster DM Healthcare
742.40
38,465.31
89.59
4,643.22
8.32
384
#1 79.65
65.49
Narayana Hrudayalaya
1,820.30
37,199.80
48.84
5,575.00
12.29
790
-34.33
56.58
Global Health
1,200.60
32,270.97
63.55
3,771.40
12.59
481
-33.52
67.28
Krishna Institute of Medical Sciences
717.60
28,713.97
89.90
3,067.00
21.98
415
-43.89
66.13
Dr. Agarwal's Health Care
454.60
14,402.07
89.01
1,757.00
27.64
110
54.61
56.81
Rainbow Childrens Medicare
1,304.50
13,248.39
50.49
1,566.90
17.46
244
7.26
63.97
Park Medi World
249.75
10,787.47
#1 39.44
1,426.00
12.90
213
15.54
73.89
Growth Rate
Revenue Growth
14.76 %
Net Income Growth
60.97 %
Cash Flow Change
11.26 %
ROE
36.18 %
ROCE
2.58 %
EBITDA Margin (Avg.)
12.43 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
2,215
2,415
2,508
2,522
2,582
2,850
2,922
3,125
2,179
2,808
2,781
2,931
4,079
3,725
3,662
3,580
3,812
4,274
4,299
4,322
4,452
4,873
4,880
4,981
5,134
5,633
5,596
5,664
5,896
6,365
6,545
Expenses
1,981
2,141
2,222
2,220
2,218
2,427
2,482
2,542
2,159
2,470
2,370
2,456
3,245
3,102
3,052
3,083
3,317
3,699
3,780
3,814
3,909
4,219
4,237
4,303
4,411
4,774
4,765
4,823
4,990
5,362
5,531
EBITDA
234
274
286
302
364
423
440
583
21
337
411
475
835
623
610
497
495
575
519
508
543
654
643
677
724
859
831
841
906
1,002
1,014
Operating Profit %
10 %
11 %
11 %
11 %
14 %
15 %
15 %
13 %
1 %
11 %
14 %
14 %
14 %
17 %
16 %
13 %
13 %
13 %
11 %
11 %
12 %
13 %
13 %
13 %
13 %
15 %
14 %
14 %
15 %
15 %
15 %
Depreciation
95
97
98
105
144
155
157
164
160
149
125
139
141
145
149
166
148
155
153
159
167
163
167
190
177
185
185
211
215
218
219
Interest
76
81
84
85
126
134
137
135
127
122
101
99
95
95
94
95
93
93
100
95
106
111
113
119
116
118
110
115
108
110
113
Profit Before Tax
63
96
103
112
94
134
145
284
-267
66
185
238
599
383
368
236
254
327
266
254
270
379
363
368
430
557
536
516
583
675
682
Tax
39
42
53
39
45
51
55
74
-41
7
51
68
99
116
124
139
-70
114
104
108
97
130
109
110
115
162
157
101
142
181
166
Net Profit
23
54
50
73
49
83
90
210
-226
59
134
170
501
267
243
97
324
213
162
146
173
249
254
258
316
396
379
415
441
494
516
EPS in ₹
2.44
4.56
4.10
6.10
4.11
6.20
6.62
15.77
-14.96
4.33
9.38
11.77
34.03
17.24
15.88
6.27
22.05
14.19
10.67
10.05
11.59
16.20
17.06
17.65
21.23
26.34
25.89
27.10
30.10
33.19
34.94
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
6,479
7,360
8,119
8,613
9,183
11,338
11,417
13,269
14,428
16,753
20,657
Fixed Assets
3,244
3,997
4,591
4,773
4,982
7,432
6,778
8,296
8,520
9,664
10,988
Current Assets
1,939
1,975
2,129
2,220
2,282
2,647
3,641
4,061
4,337
5,280
7,029
Capital Work in Progress
533
562
347
712
822
236
234
46
610
873
921
Investments
146
352
406
352
462
434
1,343
816
574
986
2,487
Other Assets
2,557
2,448
2,775
2,776
2,918
3,237
3,062
4,112
4,725
5,230
6,261
Total Equity & Liabilities
6,479
7,360
8,119
8,613
9,183
11,338
11,417
13,269
14,428
16,753
20,657
Current Liabilities
1,076
1,250
963
1,567
1,956
2,337
2,038
2,434
3,325
4,665
4,579
Non Current Liabilities
2,159
2,701
3,718
3,662
3,759
5,531
4,577
4,932
4,572
4,768
7,426
Total Equity
3,244
3,409
3,438
3,384
3,469
3,470
4,802
5,903
6,531
7,321
8,653
Reserve & Surplus
3,101
3,262
3,240
3,182
3,264
3,270
4,531
5,551
6,126
6,864
8,140
Share Capital
70
70
70
70
70
70
72
72
72
72
72
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
103
39
-52
24
-20
95
45
158
-113
72
73
Investing Activities
-759
-888
-1,152
-405
-711
-289
-880
-747
-857
-1,537
-3,381
Operating Activities
470
597
623
537
905
1,293
1,265
1,696
1,377
1,920
2,136
Financing Activities
392
330
477
-109
-215
-910
-340
-792
-633
-311
1,317
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
29.82 %
29.82 %
29.82 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.34 %
29.34 %
28.02 %
28.02 %
28.02 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
45.63 %
43.92 %
45.37 %
45.27 %
42.74 %
43.49 %
44.20 %
43.54 %
42.62 %
DIIs
9.16 %
10.84 %
12.24 %
12.13 %
12.45 %
14.89 %
14.59 %
16.56 %
17.76 %
16.31 %
18.60 %
17.97 %
19.55 %
21.14 %
19.95 %
19.98 %
22.29 %
21.34 %
21.12 %
21.51 %
22.76 %
Government
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
Public / Retail
4.07 %
3.99 %
4.24 %
4.03 %
4.27 %
4.48 %
4.23 %
4.13 %
4.04 %
3.90 %
4.04 %
3.70 %
3.74 %
3.81 %
3.62 %
3.65 %
3.81 %
3.98 %
4.44 %
4.70 %
4.39 %
Others
56.73 %
55.13 %
53.47 %
54.29 %
53.73 %
51.07 %
51.63 %
49.75 %
48.64 %
50.23 %
47.80 %
48.76 %
1.52 %
1.57 %
1.50 %
1.54 %
1.60 %
1.62 %
1.99 %
2.01 %
1.98 %
No of Share Holders
67,091
75,153
98,452
99,135
1,26,226
1,46,320
1,35,923
1,31,636
1,31,937
1,20,030
1,31,565
1,19,578
1,30,664
1,27,754
1,19,245
1,27,802
1,34,058
1,41,007
1,60,556
1,78,648
1,74,610

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 6 5 6 6 3 11.75 15 16 12.66 0.00
Dividend Yield (%) 0.56 0.41 0.53 0.21 0.07 0.27 0.24 0.24 0.17 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 20 May 2026 7,639.20 8,097.00
21 Aug 2021 DIVIDEND Dividend
₹ 3.00 /share
 18 Aug 2021 3,244.80 4,746.50
20 Aug 2022 DIVIDEND Dividend
₹ 11.75 /share
 18 Aug 2022 3,524.30 4,135.35
24 Feb 2023 DIVIDEND Dividend
₹ 6.00 /share
 24 Feb 2023 4,355.10 4,448.85
19 Aug 2023 DIVIDEND Dividend
₹ 9.00 /share
 18 Aug 2023 4,646.10 4,848.35
20 Feb 2024 DIVIDEND Dividend
₹ 6.00 /share
 20 Feb 2024 6,179.35 6,656.25
17 Aug 2024 DIVIDEND Dividend
₹ 10.00 /share
 16 Aug 2024 5,903.45 6,686.90
30 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 30 Aug 2024 6,704.00 6,855.95
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Nov 2024 7,092.60 6,966.30
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 10 Feb 2025 6,828.10 6,790.55
15 Feb 2025 DIVIDEND Dividend
₹ 9.00 /share
 14 Feb 2025 6,790.55 6,266.65
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 May 2025 6,974.00 6,923.00
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2025 7,352.50 7,259.00
19 Aug 2025 DIVIDEND Dividend
₹ 10.00 /share
 19 Aug 2025 6,923.00 7,822.50
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Aug 2025 6,923.00 7,726.60
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Nov 2025 7,671.00 7,813.25
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 10 Feb 2026 7,272.50 7,211.30
16 Feb 2026 DIVIDEND Dividend
₹ 10.00 /share
 16 Feb 2026 7,211.30 7,538.25

Announcements

Announcement under Regulation 30 (LODR)-Scheme of Arrangement2 days ago
Board Meeting Intimation for As Per Annexure Enclosed6 days ago
Announcement under Regulation 30 (LODR)-Scheme of ArrangementApr 27, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementApr 18, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 10, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementApr 10, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementApr 03, 2026
Board Meeting Outcome for Outcome Of The Board MeetingApr 02, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMar 31, 2026
Closure of Trading WindowMar 24, 2026
Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations)Mar 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Announcement under Regulation 30 (LODR)-AcquisitionFeb 10, 2026
Record DateFeb 10, 2026
Corporate Action-Board approves DividendFeb 10, 2026
Announcement under Regulation 30 (LODR)-Date of payment of DividendFeb 10, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesFeb 10, 2026
Board Meeting Outcome for Announcement On Outcome Of The Board MeetingFeb 10, 2026
Update on board meetingFeb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Announcement under Regulation 30 (LODR)-Credit RatingJan 27, 2026
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 27, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 27, 2026
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations).Jan 21, 2026
Board Meeting Intimation for Notice Of The Board MeetingJan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Closure of Trading WindowDec 26, 2025
Subject: Receipt Of Observation Letter From The BSE Limited (BSE) In Relation To The Proposed Composite Scheme Of Arrangement Amongst Apollo Hospitals Enterprise Limited (Company) Apollo Healthco Limited (Transferor Company 1) Keimed Private Limited (TranDec 24, 2025
Subject: Receipt Of Observation Letter With No Objection From The National Stock Exchange Of India Limited (NSE) In Relation To The Proposed Composite Scheme Of Arrangement Amongst Apollo Hospitals Enterprise Limited (Company) Apollo Healthco Limited (TraDec 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Intimation Of Receipt Of In - Principle Approval From BSE Limited And National Stock Exchange Of India Limited For Issue And Allotment Of Maximum Of 2156770 Equity Shares Of Rs.5/- Each Under Apollo Hospitals Enterprise Limited - Employee Stock Option PlaNov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 30, 2025
Board Meeting Intimation for Notice Of The Board MeetingOct 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionOct 04, 2025
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations).Sep 24, 2025
Closure of Trading WindowSep 23, 2025
Announcement under Regulation 30 (LODR)-AcquisitionSep 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 12, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Axis Services Opportunities Fund Direct-Growth
0.00%
-87737
-4.51%
-4.09%
Franklin India Multi Asset Allocation Fund Direct-Growth
0.00%
-59440
-1.73%
-1.70%
SBI Quality Fund Direct-Growth
0.00%
-58000
-2.05%
-2.02%
Bandhan Healthcare Fund Direct-Growth
0.00%
-33000
-8.97%
-8.76%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-22500
-3.24%
-4.15%
Bank of India Mid Cap Fund Direct-Growth
0.00%
-19000
-2.21%
-2.19%
Sundaram Multi-Factor Fund Direct-Growth
0.00%
-10403
-0.89%
-0.81%
Baroda BNP Paribas ESG Best-in-class strategy Fund Direct-Growth
0.00%
-9000
-1.05%
0.00%
Mirae Asset Infrastructure Fund Direct-Growth
0.00%
-8940
-2.01%
-1.86%
Kotak Dividend Yield Fund Direct-Growth
0.00%
-7300
-2.65%
-2.09%
Unifi Flexi Cap Fund Direct-Growth
0.00%
-6702
-3.00%
-2.93%
Motilal Oswal Services Fund Direct-Growth
0.00%
-5599
-4.30%
-4.23%
HDFC Nifty India Consumption Index Fund Direct-Growth
0.00%
-4701
-2.57%
-2.46%
Parag Parikh Large Cap Fund Direct-Growth
0.00%
-4458
-0.60%
-0.58%
Nippon India BSE Sensex Next 30 Index Fund Direct-Growth
0.00%
-3165
-3.24%
-3.06%
SBI Nifty100 Low Volatility 30 Index Fund Direct-Growth
0.00%
-2727
-3.60%
-3.73%
JioBlackRock Nifty 50 Index Fund Direct-Growth
0.00%
-2199
-0.75%
-0.70%
The Wealth Company Multi Asset Allocation Fund Direct-Growth
0.00%
-2053
-1.07%
-1.33%
DSP Nifty Healthcare Index Fund Direct-Growth
0.00%
-1737
-7.91%
-8.02%
Nippon India Nifty 500 Low Volatility 50 Index Fund Direct-Growth
0.00%
-1469
-3.64%
-3.44%
WhiteOak Capital Equity Savings Fund Direct-Growth
0.00%
-1000
-0.32%
-0.32%
Bajaj Finserv Equity Savings Fund Direct-Growth
0.00%
-831
-1.97%
-1.53%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-694
-0.44%
-0.46%
Zerodha Nifty 50 Index Fund Direct-Growth
0.00%
-444
-0.74%
-0.70%
Bajaj Finserv Nifty 50 Index Fund Direct-Growth
0.00%
-353
-0.74%
-0.70%

Technical Indicators

RSI(14)
Neutral
68.54
ATR(14)
Volatile
160.92
STOCH(9,6)
Neutral
65.34
STOCH RSI(14)
Neutral
79.43
MACD(12,26)
Bullish
26.04
ADX(14)
Weak Trend
12.38
UO(9)
Bearish
64.57
ROC(12)
Uptrend And Accelerating
4.56
WillR(14)
Overbought
-3.25
Bearish
2
Neutral
4
Bullish
3

About Apollo Hospitals

Apollo Hospitals Enterprise Limited (AHEL) is a leading private healthcare provider in Asia. It operates a network of hospitals, pharmacies, primary care clinics, and diagnostic centers. As of March 31, 2023, AHEL had a capacity of 9,957 beds across 70 hospitals in India and overseas. This includes 8,544 beds in...more
Website
https://www.apollohospitals.com
Chairperson NamePreetha Reddy
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104